New developments in HIV drug resistance. - Wikidata - wikimedia - TriplyDB

New developments in HIV drug resistance.

New developments in HIV drug resistance.

http://www.wikidata.org/entity/Q37578904

about

Peptides that bind the HIV-1 integrase and modulate its enzymatic activity--kinetic studies and mode of action Analytical and biological considerations in the measurement of cell-associated CCR5 and CXCR4 mRNA and protein Efficient identification of human immunodeficiency virus type 1 mutants resistant to a protease inhibitor by using a random mutant library.Specific eradication of HIV-1 from infected cultured cells Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing.No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.In search of a treatment for HIV--current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs).Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor.Hologram quantitative structure activity relationship, docking, and molecular dynamics studies of inhibitors for CXCR4.Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy.

P2860

Q24316120-46A409DD-2356-4C49-9E14-39D3646D8823 Q33962644-3BB43510-6551-4AD3-AE2B-BF5211EFCF5A Q34005107-1CA20654-57ED-4711-8FCF-AA394E64D769 Q34622660-95CF7327-E017-4E74-8DFE-2EE5EE37FF7C Q36507279-AED08525-9608-45D4-9514-ADAE707544D1 Q37146865-78636915-B67C-4FA6-82B2-97C3857FF9F2 Q38012389-AA007ABB-D2EA-4D50-B4C3-F10674A82886 Q39600778-1B5F0911-789B-4CED-9A57-1C5D85F5D0DB Q42212856-4FF774FF-79F8-4D16-BCD8-D96798DD4C5C Q47140686-7B8A3950-7418-499A-B641-106478EDC0DA

P2860

New developments in HIV drug resistance.

http://www.wikidata.org/entity/Q37578904

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New developments in HIV drug resistance.

@en

New developments in HIV drug resistance.

@nl

type

label

New developments in HIV drug resistance.

@en

New developments in HIV drug resistance.

@nl

prefLabel

New developments in HIV drug resistance.

@en

New developments in HIV drug resistance.

@nl

P1433

Q37578904-84441C05-ED8E-4E6B-817F-415A95BFE216

P1476

Q37578904-EE1B6B3D-E93B-40DC-BFC7-B4CDDF5BD386

P2093

Q37578904-DC93AC98-7BC7-4493-B195-912C44CB288E

P2860

Q37578904-3D1BF78D-AC23-4E28-8F33-B1C2642B5CC5

Q37578904-52DC27E3-2F6F-4809-8CA6-BBC89F4F67AC

Q37578904-640F9F40-9202-4EDA-8060-7401077568D3

Q37578904-747F6ED5-9412-4DFD-874A-6861F1DFFA31

Q37578904-7D9457CF-CB15-48A4-9846-017E78AD1153

Q37578904-8BE01FBF-E9D5-42C7-B618-0DA533EC68B5

Q37578904-90273C63-5E4B-45DF-93CF-38B2D04AF760

Q37578904-A573C6F2-E6D9-4F8C-987A-A24F479AD3D2

Q37578904-AE25E425-727C-4FC3-B1EA-399F2C0EE66A

Q37578904-C221F449-5B61-4ED2-9A06-A4558FD304A0

P304

Q37578904-6B19D738-0B74-4991-8AA8-AA5C84CB7E9E

P31

Q37578904-30FB7A71-D306-461A-A18A-B4ABE2F10768

P356

Q37578904-F38CFEF2-F23B-4466-873F-5094A63AB889

P407

Q37578904-5D575AC2-7873-41A0-A75E-DDA7308C330D

P478

Q37578904-292706E9-6A7E-481C-A3BA-B94A9CBE3693

P577

Q37578904-8DA7000B-F180-46AD-A71C-9A710C732837

P5875

Q37578904-5526965E-760F-47A0-9CE7-C2F9A183E2BA

P698

Q37578904-8394A71A-41B2-43AE-A359-C29F94D9C4A7

P921

Q37578904-BD833C13-BAC2-451C-A9A5-C8E2787385E4

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

New developments in HIV drug resistance.

@en

P2093

Patricia A Cane

http://www.w3.org/2001/XMLSchema#string

P2860

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance

Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.

Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors

New methods for the surveillance of HIV drug resistance in the resource poor world.

Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.

HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.

Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients.

Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues.

P304

i37-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKP258

http://www.w3.org/2001/XMLSchema#string

P407

P478

64 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51437738

http://www.w3.org/2001/XMLSchema#string

P698

19675018

http://www.w3.org/2001/XMLSchema#string

P921